BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32464112)

  • 1. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
    Maier CL; Truong AD; Auld SC; Polly DM; Tanksley CL; Duncan A
    Lancet; 2020 Jun; 395(10239):1758-1759. PubMed ID: 32464112
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe COVID-19 disease and thromboinflammation.
    Jerjes-Sánchez C
    Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
    [No Abstract]   [Full Text] [Related]  

  • 3. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of venous thromboembolism during the COVID-19 pandemic.
    Skeik N; Mirza A; Manunga J
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):897-898. PubMed ID: 32454238
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
    Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
    Di Micco P; Russo V; Lodigiani C
    Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.
    Yeh CH; de Wit K; Levy JH; Weitz JI; Vaezzadeh N; Liaw PC; Fox-Robichaud A; Soliman K; Kim PY
    J Trauma Acute Care Surg; 2020 Dec; 89(6):e177-e181. PubMed ID: 32890338
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and venous thromboembolism - prophylaxis and treatment.
    Kvåle R; Azrakhsh NA; Mohn KG; Aanerud M; Guttormsen AB; Reikvam H
    Tidsskr Nor Laegeforen; 2020 Aug; 140(11):. PubMed ID: 32815357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP; Nathan N
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
    Boonyasai RT; Murthy VK; Yuen-Gee Liu G; Garibaldi BT; Brotman DJ; Streiff MB; Omron R
    Mayo Clin Proc; 2020 Oct; 95(10):2291-2293. PubMed ID: 33012363
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
    Horowitz NA; Brenner B
    Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
    Ambrosino P; Di Minno A; Maniscalco M; Di Minno MND
    Ann Med; 2020 Sep; 52(6):239-242. PubMed ID: 32619360
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial thrombosis associated with COVID-19.
    Hamilton KV; Hussey KK
    J Vasc Surg; 2020 Aug; 72(2):757-758. PubMed ID: 32425325
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of venous thromboembolism in critically ill patients with COVID-19.
    Hippensteel JA; Burnham EL; Jolley SE
    Br J Haematol; 2020 Aug; 190(3):e134-e137. PubMed ID: 32484907
    [No Abstract]   [Full Text] [Related]  

  • 16. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
    Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
    Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.
    Wang T; Chen R; Liu C; Liang W; Guan W; Tang R; Tang C; Zhang N; Zhong N; Li S
    Lancet Haematol; 2020 May; 7(5):e362-e363. PubMed ID: 32278361
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 20. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.